Abercrombie & Fitch Co. (0R32)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 159.77 |
|---|---|
| 52-week range | 64.29 – 162.47 |
| Return, 1 month / 3 months | +17.5% / +68.2% |
| Return, 1 year / 3 years | +133.5% / +193.3% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 63.3% |
| Worst drawdown (1 year) | -46.2% |
| Average daily value traded | 0.31M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Abercrombie & Fitch Co. is an American clothing retailer based in New Albany, Ohio. It designs and sells casual apparel, including jeans, tops, outerwear and accessories, under its Abercrombie & Fitch and Hollister brands. Its customers are mainly young people, and it reaches them through its own stores, outlet locations and websites in the United States and other countries. The company also offers fragrances and other lifestyle products alongside its clothing ranges.
On this site Abercrombie & Fitch Co. appears as a stock on the London Exchange (UK), code 0R32, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Abercrombie & Fitch Co. (0R32) trades on the London Exchange in UK. It last closed at USD 159.77 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 797 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 133.5% and over the last three months it rose 68.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 98 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 55.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 97 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 68.2% | ||
| 6-month return | 77.5% | ||
| 12-month return, skipping the last month | 98.7% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.2% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.31M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +10.6% |
|---|---|
| 1 month | +17.5% |
| 3 months | +68.2% |
| 6 months | +77.5% |
| 1 year | +133.5% |
| 3 years | +193.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 135.37 / 102.59 |
|---|---|
| Golden / death cross (60 days) | Golden, 50 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Mar 2020 | USD 0.2000 |
| 5 Dec 2019 | USD 0.2000 |
| 5 Sep 2019 | USD 0.2000 |
| 6 Jun 2019 | USD 0.2000 |
| 7 Mar 2019 | USD 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.